Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression
M. Kubera et al., Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression, J AFFECT D, 63(1-3), 2001, pp. 171-178
Background Depression is associated with activation of the inflammatory res
ponse system (IRS). In humans, antidepressants significantly increase the p
roduction of interleukin-10 (IL-10), a negative immunoregulatory cytokine.
The aims of the present study were to examine the effects of desipramine, a
tricyclic antidepressant, on the IRS in C57BL/6 mice with and without expo
sure to chronic mild stress (CMS). Methods: We examined the effects of desi
pramine on the cytotoxic activity of natural killer (NK) cells, the prolife
rative responses of lymphocytes after stimulation with IL-1, IL-2, lipopoly
saccharide (LPS), concanavaline-A (Con-A), phytohaemagglutinin-P (PHA), pok
eweed mitogen (PWM), and anti-CD3 monoclonal antibodies, the production of
IL-2, IL-4, IL-10 and interferon-gamma (IFN gamma) by T lymphocytes and the
ability of B cells to proliferate after stimulation by lipopolysaccharide
(LPS). Results: Prolonged treatment of C57BL/6 mice subjected to CMS with d
esipramine increases the ability of T cells to produce IL-IO and the abilit
y of B cells to proliferate after stimulation with LPS; and significantly d
ecreases the cytotoxic activity of NK cells and the proliferative responses
of lymphocytes after stimulation with Con-A, PHA and anti-CD3 monoclonal a
ntibodies. Repeated administration of desipramine to non-stressed mice incr
eases the activity of T lymphocytes, lowers that of B lymphocytes, increase
s the production of IL-IO by T cells and has no significant effect on the a
ctivity of NK cells. Conclusion: Prolonged desipramine treatment of stresse
d and non-stressed C57BL/6 mice induces an increase in the production of IL
-IO, an anti-inflammatory cytokine. (C) 2001 Elsevier Science B.V. All righ
ts reserved.